Author information: (1)The Sol Goldman Pancreatic Cancer Research Center, Department of Pathology, Johns Hopkins University, Baltimore, United States. (2)Human Genetics Predoctoral Training Program, the McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, United States. (3)Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, United States. (4)Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, United States. (5)Department of Medicine, University of Pittsburgh, Pittsburgh, United States. (6)Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, United States. (7)Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, United States. (8)The Sol Goldman Pancreatic Cancer Research Center, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, United States. (9)Ontario Institute for Cancer Research, Toronto, Canada. (10)Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States. (11)Department of Health Sciences Research, Mayo Clinic, Rochester, United States. (12)Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, United States. (13)Department of Internal Medicine, University of Michigan, Ann Arbor, United States. (14)Dana-Farber Cancer Institute and Harvard Medical School, Boston, United States. (15)The Research Institute of the McGill University Health Centre, Quebec, Canada.